Kelly Lawrence W & Associates Inc/Ca
Source: SEC Form 13F · as of Mar 2026Kelly Lawrence W & Associates Inc/Ca holds 15 biotech & pharma companies tracked by BioSniper, totaling $33.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$33.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 47,785 | $11.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 36,549 | $9.9M |
| RGENREPLIGEN CORP | 54,470 | $6.4M |
| ABBVAbbVie Inc. | 7,941 | $1.7M |
| GILDGILEAD SCIENCES, INC. | 6,044 | $842K |
| ABTABBOTT LABORATORIES | 5,910 | $607K |
| AMGNAMGEN INC | 1,398 | $492K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 585 | $261K |
| PFEPFIZER INC | 9,130 | $256K |
| LLYELI LILLY & Co | 227 | $209K |
| MCKMcKesson Corporation | 240 | $208K |
| REGNREGENERON PHARMACEUTICALS, INC. | 263 | $203K |
| ZTSZoetis Inc. | 1,075 | $127K |
| PMPhilip Morris International Inc | 190 | $31K |
| NVONovo Nordisk A/S | 450 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.